Single Ascending Dose Study of Safety and Tolerability of SPH3127 Tablet in Chinese Healthy Volunteers
Status:
Unknown status
Trial end date:
2018-07-01
Target enrollment:
Participant gender:
Summary
1. To evaluate safety, tolerability and pharmacokinetics (PK) and pharmacodynamics (PD)
characteristics of SPH3127 dose escalation, a single oral dose in Chines healthy
volunteers.
2. To explore the appropriate dose and provide the basis for the subsequent clinical
trials.